Naropin Injection, Solution
Product Images NDC 63323-288

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Naropin (NDC 63323-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Nov0h 0003 01)

Chemical structure of Ropivacaine Hydrochloride, the active ingredient in Naropin 10 mg/mL injection, solution. The diagram depicts the molecular structure including notable functional groups and atoms arranged in the compound.*

FDA Label Image

Novaplus Logo (Nov0h 0003 02)

FDA Label Image

Bag Label (Nov0h 0003 03)

Naropin 0.2% (ropivacaine hydrochloride) Injection, USP 2 mg/mL in a 100 mL vial for infiltration, nerve block, and epidural administration only. The label states no preservatives, provides dosage details, storage instructions, and manufacturer Fresenius Kabi USA, LLC. Not for intravenous use, single dose only.*

FDA Label Image

Vial (Nov0h 0003 04)

Label for Naropin 0.5% (ropivacaine hydrochloride) injection, USP, 5 mg/mL strength, supplied as a 30 mL single-dose vial. Intended for epidural use, nerve block, and infiltration only. Labeler is Fresenius Kabi USA, LLC. The label includes storage instructions, a barcode, and trademark information for Naropin and Novaplus.*

FDA Label Image

Tray (Nov0h 0003 05)

Label for Naropin (ropivacaine hydrochloride) Injection, USP 0.5% (5 mg/mL) in 30 mL single-dose vials, with a total of 150 mg per vial. Labeled for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC. The label includes storage instructions and indicates the container is preservative-free.*

FDA Label Image

Vial (Nov0h 0003 06)

Naropin (ropivacaine hydrochloride) Injection, USP 1% solution, 200 mg per 20 mL (10 mg/mL) in a 20 mL single-dose vial. Labeled for epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC under the Novaplus brand. Includes storage instructions and a barcode.*

FDA Label Image

Tray (Nov0h 0003 07)

Naropin (ropivacaine hydrochloride) Injection, USP 1% (10 mg/mL) solution for epidural administration only, not for intravenous use. Each vial contains 200 mg per 20 mL. Single-dose 20 mL vial packaging. Label by Fresenius Kabi USA, LLC, with storage and handling instructions, ingredient details, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.